Keywords: Baxter, ApaTech, ACTIFUSE, Orthobiological, Halozyme

Baxter to acquire UK’s ApaTech, Including ACTIFUSE, in a $300 million deal

Article | 02 March 2010

Print This

US specialty drugs and medical devices firm Baxter International has entered into a definitive agreement to acquire all of the ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in